Acumen Pharmaceuticals logo

Acumen Pharmaceuticals Share Price Today

(NASDAQ: ABOS)

Acumen Pharmaceuticals share price is $1.23 & ₹106.97 as on 6 Mar 2025, 2.30 'hrs' IST

$1.23

0.02

(1.65%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Acumen Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Acumen Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Acumen Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Acumen Pharmaceuticals share price movements

  • Today's Low: $1.18
    Today's High: $1.27

    Day's Volatility :6.72%

  • 52 Weeks Low: $1.10
    52 Weeks High: $4.60

    52 Weeks Volatility :76.09%

Acumen Pharmaceuticals (ABOS) Returns

PeriodAcumen Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-41.98%
3.7%
0.0%
6 Months
-45.81%
-2.8%
0.0%
1 Year
-72.36%
2.5%
0.0%
3 Years
-76.75%
12.9%
-11.6%

Acumen Pharmaceuticals (ABOS) Key Statistics

in dollars & INR

Previous Close
$1.21
Open
$1.19
Today's High
$1.265
Today's Low
$1.18
Market Capitalization
$72.7M
Today's Volume
$202.4K
52 Week High
$4.6
52 Week Low
$1.1
Revenue TTM
$329.0K
EBITDA
$-92.8M
Earnings Per Share (EPS)
$-1.45
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-32.83%

How to invest in Acumen Pharmaceuticals Stock (ABOS) from India?

It is very easy for Indian residents to invest directly in Acumen Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Acumen Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Acumen Pharmaceuticals or ABOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Acumen Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Acumen Pharmaceuticals shares which would translate to 0.707 fractional shares of Acumen Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Acumen Pharmaceuticals, in just a few clicks!

Returns in Acumen Pharmaceuticals (ABOS) for Indian investors in Rupees

The Acumen Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Acumen Pharmaceuticals investment value today

Current value as on today

₹32,589

Returns

₹67,411

(-67.41%)

Returns from Acumen Pharmaceuticals Stock

₹72,360 (-72.36%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Acumen Pharmaceuticals (ABOS)

-30%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Acumen Pharmaceuticals Stock from India on INDmoney has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Acumen Pharmaceuticals

  • RA Capital Management, LLC

    24.85%

  • Sands Capital Ventures, LLC

    5.69%

  • Franklin Resources Inc

    5.45%

  • BlackRock Inc

    3.95%

  • FMR Inc

    3.37%

  • Vanguard Group Inc

    3.23%

Analyst Recommendation on Acumen Pharmaceuticals

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Acumen Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
12
12
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Acumen Pharmaceuticals Stock (ABOS)

What analysts predicted

Upside of 778.05%

Target:

$10.80

Current:

$1.23

Insights on Acumen Pharmaceuticals Stock (Ticker Symbol: ABOS)

  • Price Movement

    In the last 3 months, ABOS stock has moved down by -43.1%
  • ABOS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 138.9%
  • ABOS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 127.1%
  • Price to Sales

    ForABOS every $1 of sales, investors are willing to pay $37.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Acumen Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Acumen Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Acumen Pharmaceuticals (ABOS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Acumen Pharmaceuticals Inc logo
-16.89%
-45.81%
-72.36%
-76.75%
-93.49%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Acumen Pharmaceuticals Inc logo
3.26
NA
NA
-1.32
-0.33
-0.21
NA
3.62
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Acumen Pharmaceuticals Inc logo
Buy
$72.7M
-93.49%
3.26
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Acumen Pharmaceuticals

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Organization
Acumen Pharmaceuticals
Employees
51
CEO
Mr. Daniel J. O'Connell M.B.A.
Industry
Healthcare

Management People of Acumen Pharmaceuticals

NameTitle
Mr. Daniel J. O'Connell M.B.A.
CEO & Director
Mr. Matt Zuga
CFO & Chief Business Officer
Mr. Derek M. Meisner Esq., J.D.
Chief Legal Officer & Corporate Secretary
Dr. James Doherty Ph.D.
President & Chief Development Officer
Dr. Grant A. Krafft Ph.D.
Co-Founder
Dr. Caleb E. Finch Ph.D.
Co-Founder
Dr. William L. Klein Ph.D.
Co-Founder
Mr. Russell Barton M.S.
Chief Operating Officer
Ms. Kelly Carranza
Vice President, Finance & Accounting and Corporate Controller
Ms. Alex Braun M.B.A.
VP & Head of Investor Relations

Important FAQs about investing in ABOS Stock from India :

What is Acumen Pharmaceuticals share price today?

Acumen Pharmaceuticals share price today stands at $1.23, Open: $1.19 ; Previous Close: $1.21 ; High: $1.27 ; Low: $1.18 ; 52 Week High: $4.60 ; 52 Week Low: $1.10.

The stock opens at $1.19, after a previous close of $1.21. The stock reached a daily high of $1.27 and a low of $1.18, with a 52-week high of $4.60 and a 52-week low of $1.10.

Can Indians buy Acumen Pharmaceuticals shares?

Yes, Indians can invest in the Acumen Pharmaceuticals (ABOS) from India.

With INDmoney, you can buy Acumen Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Acumen Pharmaceuticals at zero transaction cost.

How can I buy Acumen Pharmaceuticals shares from India?

It is very easy to buy Acumen Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Acumen Pharmaceuticals (ABOS) be purchased?

Yes, you can buy fractional shares of Acumen Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Acumen Pharmaceuticals stocks?

To start investing in Acumen Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Acumen Pharmaceuticals Stock (ABOS)?

Today’s highest price of Acumen Pharmaceuticals (ABOS) is $1.27.

Today’s lowest price of Acumen Pharmaceuticals (ABOS) is $1.18.

What is today's market capitalisation of Acumen Pharmaceuticals?

Today's market capitalisation of Acumen Pharmaceuticals ABOS is 72.7M

What is the 52 Week High and Low Range of Acumen Pharmaceuticals Stock (ABOS)?

  • 52 Week High

    $4.60

  • 52 Week Low

    $1.10

What are the historical returns of Acumen Pharmaceuticals (ABOS)?

  • 1 Month Returns

    -16.89%

  • 3 Months Returns

    -45.81%

  • 1 Year Returns

    -72.36%

  • 5 Years Returns

    -93.49%

Who is the Chief Executive Officer (CEO) of Acumen Pharmaceuticals ?

Mr. Daniel J. O'Connell M.B.A. is the current Chief Executive Officer (CEO) of Acumen Pharmaceuticals.

Discover More